Jonathan Cotliar - Apr 28, 2023 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role
Chief Medical Officer
Signature
/s/ Christine Pellizzari, Attorney-in-fact for Jonathan Cotliar
Stock symbol
SNCE
Transactions as of
Apr 28, 2023
Transactions value $
$0
Form type
4
Date filed
5/2/2023, 04:24 PM
Previous filing
Aug 16, 2022
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Award +257 K +37.47% 944 K Apr 28, 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Disposed to Issuer -443 K -100% 0 Apr 28, 2023 Common Stock 443 K $10.05 Direct F1
transaction SNCE Stock Option Disposed to Issuer -201 K -100% 0 Apr 28, 2023 Common Stock 201 K $11.47 Direct F2

Explanation of Responses:

Id Content
F1 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 442,754 shares of common stock of the issuer and in exchange issued to the reporting person 177,101 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F2 On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 200,549 shares of common stock of the issuer and in exchange issued to the reporting person 80,219 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.
F3 Includes 257,320 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.